Q/C TECHNOLOGIES, INC.
For the period ended Dec 31, 2025. Filed Apr 15, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Apr 15, 2026
QCLS$0.37+8.8%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Balance Sheets
December 31, 2025 and 2024
| As of | ||
|---|---|---|
| December 31, 2025 | December 31, 2024 | |
| ASSETS | ||
| Current Assets | ||
| Cash and Cash Equivalents | $986,996 | $173,154 |
| Marketable Securities | 14,801,267 | 8,345,082 |
| Deposits and Other Receivables | 18,200 | - |
| Prepaid Expenses | 774,095 | 893,730 |
| Total Current Assets | 16,580,558 | 9,411,966 |
| Non-Current Assets | ||
| Operating Lease Right-of-Use Assets | - | 10,579 |
| Intangible Assets | 14,086,999 | - |
| Goodwill | 10,498,539 | 10,498,539 |
| Investment in Oravax, Inc. | - | 1,500,000 |
| Total Non-Current Assets | 24,585,538 | 12,009,118 |
| Total Assets | $41,166,096 | $21,421,084 |
| LIABILITIES | ||
| Current Liabilities | ||
| Trade and Other Payables | $2,445,346 | $2,902,104 |
| Due to MyMD Florida Shareholders | 29,982 | 29,982 |
| Operating Lease Liability | - | 10,579 |
| Derivative Liabilities | 2,157,000 | 1,303,000 |
| Dividends Payable | 365,970 | 2,455,675 |
| License Fee Payable | 533,744 | - |
| Total Current Liabilities | 5,532,042 | 6,701,340 |
| Non-Current Liabilities | ||
| Contingent Consideration Payable | 10,909,000 | - |
| Total Non-Current Liabilities | 10,909,000 | - |
| Total Liabilities | $16,441,042 | $6,701,340 |
| Commitments and Contingencies – Note 8 | - | - |
| Mezzanine Equity | ||
| Series F Convertible Preferred Stock, 15,000 shares designated, $0.001 par value per share and a stated value of $1,000 per share, 0 and 4,211 shares issued and outstanding as of December 31, 2025 and December 31, 2024. | - | 4,930,004 |
| Series F-1 Convertible Preferred Stock, 5,050 shares designated, $0.001 par value per share and a stated value of $1,100 per share, 0 and 4,747 shares issued and outstanding as of December 31, 2025 and December 31, 2024. | - | 4,744,101 |
| Series F-1 Convertible Preferred Stock – Discount | - | (4,744,101) |
| Series G Convertible Preferred Stock, 12,826,273 shares designated, $0.001 par value per share and a stated value of $1,000 per share, 8,804 and 8,884 shares issued and outstanding as of December 31, 2025 and December 31, 2024. Liquidation preference of 8,804,000 plus dividends at 10% per annum of $10,977 as of December 31, 2025 | 8,802,000 | 8,884,000 |
| Series G Convertible Preferred Stock – Discount | (6,938,000) | (8,884,000) |
| Series H Convertible Preferred Stock, 7,000 shares designated, par value of $0.001 and a stated value of $1,000 per share, 3,115 and 0 shares issued and outstanding as of December 31, 2025 and December 31, 2024. Liquidation preference of $3,115,000 plus dividends at 5% per annum of $78,750 as of December 31, 2025 | 3,115,000 | - |
| Series H Convertible Preferred Stock - Discount | (168,621) | - |
| Series H Convertible Preferred Stock - Derivative | (1,837,000) | - |
| Series I Convertible Preferred Stock, 747,362 shares designated, par value of $0.001 and a stated value of $0.01 per share, 0 and 0 shares issued and outstanding as of December 31, 2025 and December 31, 2024 | - | - |
| Total Mezzanine Equity | 2,973,379 | 4,930,004 |
| STOCKHOLDERS’ EQUITY | ||
| Preferred Stock, par value $0.001, 50,000,000 total preferred shares authorized and 0 shares issued and outstanding as of December 31, 2025 and December 31, 2024 | ||
| Series D Convertible Preferred Stock, 211,353 shares designated, $0.001 par value per share and a stated value of $0.01 per share, 72,992 and 72,992 shares issued and outstanding as of December 31, 2025 and December 31, 2024 | 144,524 | 144,524 |
| Common Stock, par value $0.001, 1,250,000,000 shares authorized 7,690,403 and 33,636 shares issued and outstanding as of December 31, 2025 and December 31, 2024 | 184,502 | 3,364 |
| Additional Paid in Capital | 165,545,382 | 138,780,138 |
| Accumulated Deficit | (144,122,733) | (129,138,286) |
| Total Stockholders’ Equity | 21,751,675 | 9,789,740 |
| Total Liabilities and Stockholders’ Equity | $41,166,096 | $21,421,084 |
The accompanying notes are an integral part of these consolidated financial statements
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.